NO934145L - Farmasöytiske forbindelser - Google Patents

Farmasöytiske forbindelser

Info

Publication number
NO934145L
NO934145L NO934145A NO934145A NO934145L NO 934145 L NO934145 L NO 934145L NO 934145 A NO934145 A NO 934145A NO 934145 A NO934145 A NO 934145A NO 934145 L NO934145 L NO 934145L
Authority
NO
Norway
Prior art keywords
pharmaceutical compounds
pharmaceutical
compounds
Prior art date
Application number
NO934145A
Other languages
English (en)
Other versions
NO934145D0 (no
NO304890B1 (no
Inventor
Colin Peter Dell
Andrew Caerwyn Williams
Original Assignee
Lilly Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929224169A external-priority patent/GB9224169D0/en
Priority claimed from GB939302367A external-priority patent/GB9302367D0/en
Application filed by Lilly Industries Ltd filed Critical Lilly Industries Ltd
Publication of NO934145D0 publication Critical patent/NO934145D0/no
Publication of NO934145L publication Critical patent/NO934145L/no
Publication of NO304890B1 publication Critical patent/NO304890B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO934145A 1992-11-18 1993-11-16 Farmas°ytiske forbindelser og farmas°ytiske preparater NO304890B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929224169A GB9224169D0 (en) 1992-11-18 1992-11-18 Pharmaceutical compounds
GB939302367A GB9302367D0 (en) 1993-02-06 1993-02-06 Pharmaceutical compounds

Publications (3)

Publication Number Publication Date
NO934145D0 NO934145D0 (no) 1993-11-16
NO934145L true NO934145L (no) 1994-05-19
NO304890B1 NO304890B1 (no) 1999-03-01

Family

ID=26301995

Family Applications (1)

Application Number Title Priority Date Filing Date
NO934145A NO304890B1 (no) 1992-11-18 1993-11-16 Farmas°ytiske forbindelser og farmas°ytiske preparater

Country Status (16)

Country Link
US (1) US5434160A (no)
EP (2) EP1004584A3 (no)
JP (1) JPH06199862A (no)
KR (1) KR940011465A (no)
CN (1) CN1040982C (no)
AU (1) AU668602B2 (no)
CA (1) CA2103203A1 (no)
CO (1) CO4130335A1 (no)
CZ (1) CZ243493A3 (no)
FI (1) FI103727B1 (no)
HU (1) HU9303261D0 (no)
IL (1) IL107627A (no)
NO (1) NO304890B1 (no)
NZ (1) NZ250195A (no)
PL (1) PL301059A1 (no)
TW (1) TW289755B (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9306062D0 (en) * 1993-03-24 1993-05-12 Lilly Industries Ltd Pharmaceutical compounds
FR2795071B1 (fr) * 1999-06-16 2001-07-27 Adir Nouveaux derives de carboxylate de 7-oxo-2,3,7,14- tetrahydro-1h-benzo[b]pyrano[3,2,h] acridine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
SI1230232T1 (en) 1999-11-05 2004-08-31 Cytovia, Inc. Substituted 4h-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof
US7015328B2 (en) 2001-05-16 2006-03-21 Cytovia, Inc. Substituted coumarins and quinolines and analogs as activators of caspases and inducers of apoptosis and the use thereof
WO2002092594A1 (en) 2001-05-16 2002-11-21 Cytovia, Inc. Substituted 4h-chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof
US6858607B1 (en) 2001-05-16 2005-02-22 Cytovia, Inc. 7,8-fused 4H-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof
EP1513515A2 (en) 2002-05-16 2005-03-16 Cytovia, Inc. Substituted 4h-chromenes, 2h-chromenes, chromans and analogs as activators of caspases and inducers of apoptosis and the use thereof
EP1509515A4 (en) * 2002-05-16 2006-07-05 Cytovia Inc SUBSTITUTED 4-ARYL-4H-PYRROLO 2,3-H | CHROMENES AND ANALOGUES AS ACTIVATORS OF CASPASES AND INDUCERS OF APOPTOSIS AND THEIR USE
KR20070100878A (ko) * 2004-09-09 2007-10-12 하워드 플로리 인스티튜트 오브 익스페러멘틀 피지알러지 앤드 메디신 효소 억제제 및 그 용도
US7843312B2 (en) * 2006-12-12 2010-11-30 Honeywell International Inc. Wireless control of security system with key-operated key fob
NZ585338A (en) 2007-11-19 2012-08-31 Howard Florey Inst Insulin-regulated aminopeptidase (irap) inhibitors and uses thereof
AU2011328074B2 (en) 2010-11-12 2016-05-05 Deutsches Krebsforschungszentrum (Dkfz) Chromene derivatives and their analoga as Wnt pathway antagonists
WO2023099589A1 (en) * 2021-12-01 2023-06-08 INSERM (Institut National de la Santé et de la Recherche Médicale) Irap inhibitors for use in the treatment of inflammatory diseases
CN115028643B (zh) * 2022-06-10 2024-03-22 中国药科大学 吡喃并喹啉衍生物及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4243674A (en) * 1978-06-12 1981-01-06 Pfizer Inc. 9-Hydroxydibenzo[b,d]pyrans and intermediates therefore
EP0181351A4 (en) * 1984-05-09 1989-06-21 Univ Australian METHOD FOR MODULATING IMMUNE REACTION.
JP2631710B2 (ja) * 1988-08-16 1997-07-16 日本ヘキスト・マリオン・ルセル株式会社 ピラノ〔ｆ〕キノリノン誘導体及び該化合物を有効成分とする医薬組成物
US4931221A (en) * 1988-12-30 1990-06-05 Ppg Industries, Inc. Photochromic spiropyran compounds
US5284868A (en) * 1991-10-09 1994-02-08 Eli Lilly And Company Pharmaceutical compounds
GB9306062D0 (en) * 1993-03-24 1993-05-12 Lilly Industries Ltd Pharmaceutical compounds

Also Published As

Publication number Publication date
FI103727B (fi) 1999-08-31
IL107627A (en) 1997-04-15
FI935065A0 (fi) 1993-11-16
IL107627A0 (en) 1994-02-27
CN1092072A (zh) 1994-09-14
EP0599514A3 (en) 1994-07-06
JPH06199862A (ja) 1994-07-19
PL301059A1 (en) 1994-05-30
NO934145D0 (no) 1993-11-16
CN1040982C (zh) 1998-12-02
NO304890B1 (no) 1999-03-01
CZ243493A3 (en) 1994-06-15
EP1004584A2 (en) 2000-05-31
FI935065A (fi) 1994-05-19
US5434160A (en) 1995-07-18
AU668602B2 (en) 1996-05-09
NZ250195A (en) 1995-12-21
CO4130335A1 (es) 1995-02-13
FI103727B1 (fi) 1999-08-31
TW289755B (no) 1996-11-01
KR940011465A (ko) 1994-06-21
HU9303261D0 (en) 1994-03-28
EP1004584A3 (en) 2000-07-05
CA2103203A1 (en) 1994-05-19
AU5067193A (en) 1994-06-02
EP0599514A2 (en) 1994-06-01

Similar Documents

Publication Publication Date Title
NO179941C (no) Farmasöytisk forbindelse
NO942923L (no) Medikamenter
FI921060A (fi) Farmaceutiska aerosolformuleringar
FI922958A (fi) Farmaceutisk sammansaettning
FI922252A (fi) Farmaceutisk sammansaettning
FI922316A (fi) Farmaceutisk sammansaettning
NO930543D0 (no) Doseringsform
NO920067D0 (no) Foradditiv for droevtyggere
FI931736A0 (fi) Biodegraderbart tgf-b-leveranssystem foer benregeneration
FI923581A (fi) Farmaceutisk kombinationsformation
PT589843E (pt) Composicoes farmaceuticas contendo ciclosporinas
NO931831D0 (no) Farmasoeytiske blandinger
BR9610214A (pt) Compostos farmacéuticos
NO934145L (no) Farmasöytiske forbindelser
FI931251A (fi) Farmaceutiska foereningar
NO961589D0 (no) Farmasöytiske blandinger
DK138592D0 (da) Tabletter
FI921786A (fi) Farmaceutisk foerening
FI934387A0 (fi) 3-substituerade 2-oxi-indol-1-karboxiamid omfattande farmaceutiska kompositioner
NO930791D0 (no) Substituerte tinnsilikatforbindelser
FI921785A (fi) Farmaceutisk foerening
NO965448D0 (no) Farmasöytiske forbindelser
FI930710A (fi) Anordning foer oevervakning av vaetskenivao
FI934317A0 (fi) Farmaceutiska sammansaettningar, vilka innehaoller ej-joniska ytaktiva aemnen
BR9206845A (pt) Composto famacêutico

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN MAY 2001